The DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.
Molecular and cellular mechanisms of the anabolic effect of intermittent PTH
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Manolagas, S. C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0395 · Cited by 2,568
Weinstein, R. S., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2799 · Cited by 1,753 · cited 5×
“Consistent with this notion, the reduced osteoblast number and bone formation rate observed in mice and humans receiving glucocorticoids [31], as well as in aging mice [32], is associated with increased osteoblast apoptosis.”
BackgroundResultInfluentialSelf-citation(2020) · Elsevier eBooks · doi:10.1016/c2015-1-01622-2 · Cited by 1,683
Regulation of bone mass by Wnt signaling
Krishnan, V. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28551 · Cited by 1,407
Sclerostin Binds to LRP5/6 and Antagonizes Canonical Wnt Signaling
Li, X., Zhang, Y., Kang, H., Liu, W., Liu, P., Zhang, J., Harris, S. E., & Wu, D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413274200 · Cited by 1,366 · cited 2×
“It is possible that Wnt signaling is not completely lost in LRP5 null mice because they still express LRP6, which can also be activated by Wnts.”
BackgroundBlack, D. M., Greenspan, S. L., Ensrud, K. E., Palermo, L., McGowan, J. A., Lang, T. F., Garnero, P., Bouxsein, M. L., Bilezikian, J. P., & Rosen, C. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa031975 · Cited by 1,174
Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone
Jilka, R. L., Weinstein, R. S., Bellido, T., Roberson, P., Parfitt, A. M., & Manolagas, S. C. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6610 · Cited by 1,043
Self-citationRodda, S. J., & McMahon, A. P. (2006) · Development · doi:10.1242/dev.02480 · Cited by 1,010
The role of the cyclin-dependent kinase inhibitor p21 in apoptosis.
Gartel, A. L., & Tyner, A. L. (2002) · PubMed · Cited by 918
van Bezooijen, R. L., Roelen, B. A. J., Visser, A., van der Wee-Pals, L., de Wilt, E., Karperien, M., Hamersma, H., Papapoulos, S. E., ten Dijke, P., & Löwik, C. W. G. M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031454 · Cited by 892
PPAR γ insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors
Akune, T., Ohba, S., Kamekura, S., Yamaguchi, M., Chung, U.-I., Kubota, N., Terauchi, Y., Harada, Y., Azuma, Y., Nakamura, K., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19900 · Cited by 869
Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis
Justesen, J., Stenderup, K., Ebbesen, E. N., Mosekilde, L., Steiniche, T., & Kassem, M. (2001) · Biogerontology · doi:10.1023/a:1011513223894 · Cited by 840
The Effects of Parathyroid Hormone, Alendronate, or Both in Men with Osteoporosis
Finkelstein, J. S., Hayes, A., Hunzelman, J. L., Wyland, J. J., Lee, H., & Neer, R. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035725 · Cited by 829
O’Brien, C. A., Jia, D., Plotkin, L. I., Bellido, T., Powers, C. C., Stewart, S. A., Manolagas, S. C., & Weinstein, R. S. (2004) · Endocrinology · doi:10.1210/en.2003-0990 · Cited by 771
Hodsman, A. B., Bauer, D. C., Dempster, D. W., Dian, L., Hanley, D. A., Harris, S. T., Kendler, D. L., McClung, M. R., Miller, P. D., Olszynski, W. P., et al. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0006 · Cited by 718
Osteoclast-derived activity in the coupling of bone formation to resorption
Martin, T. J., & Sims, N. A. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.12.004 · Cited by 659
Bellido, T., Ali, A. A., Gubrij, I., Plotkin, L. I., Fu, Q., O’Brien, C. A., Manolagas, S. C., & Jilka, R. L. (2005) · Endocrinology · doi:10.1210/en.2005-0239 · Cited by 641
Self-citationSOST is a target gene for PTH in bone
Keller, H., & Kneissel, M. (2005) · Bone · doi:10.1016/j.bone.2005.03.018 · Cited by 616
Dobnig, H. (1995) · Endocrinology · doi:10.1210/en.136.8.3632 · Cited by 615
(2002) · Elsevier eBooks · doi:10.1016/b978-0-12-098652-1.x5100-2 · Cited by 591
Osteoblast Programmed Cell Death (Apoptosis): Modulation by Growth Factors and Cytokines
Jilka, R. L., Weinstein, R. S., Bellido, T., Parfitt, A. M., & Manolagas, S. C. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.5.793 · Cited by 578 · cited 4×
“In normal mice, about 1 in 150 osteoblasts are undergoing apoptosis at a given moment as determined by TUNEL in our original study [30].”
BackgroundResultInfluentialSelf-citationLane, N. E., Sanchez, S., Modin, G. W., Genant, H. K., Pierini, E., & Arnaud, C. D. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3914 · Cited by 529
High Bone Mass in Mice Expressing a Mutant LRP5 Gene
Babij, P., Zhao, W., Small, C., Kharode, Y., Yaworsky, P. J., Bouxsein, M. L., Reddy, P. S., Bodine, P. V., Robinson, J. A., Bhat, B., et al. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.6.960 · Cited by 497
Aguirre, J. I., Plotkin, L. I., Stewart, S. A., Weinstein, R. S., Parfitt, A. M., Manolagas, S. C., & Bellido, T. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060107 · Cited by 494
Differential Effects of Teriparatide on BMD After Treatment With Raloxifene or Alendronate
Ettinger, B., Martin, S. J., Crans, G., & Pavo, I. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040117 · Cited by 487
Gesty-Palmer, D., Chen, M., Reiter, E., Ahn, S., Nelson, C. D., Wang, S., Eckhardt, A. E., Cowan, C. L., Spurney, R. F., Luttrell, L. M., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513380200 · Cited by 476
Rosiglitazone Causes Bone Loss in Mice by Suppressing Osteoblast Differentiation and Bone Formation
Ali, A. A., Weinstein, R. S., Stewart, S. A., Parfitt, A. M., Manolagas, S. C., & Jilka, R. L. (2005) · Endocrinology · doi:10.1210/en.2004-0735 · Cited by 444
Self-citationMa, Y. L., Cain, R. L., Halladay, D. L., Yang, X., Zeng, Q., Miles, R. R., Chandrasekhar, S., Martin, T. J., & Onyia, J. E. (2001) · Endocrinology · doi:10.1210/endo.142.9.8356 · Cited by 428
Sawakami, K., Robling, A. G., Ai, M., Pitner, N. D., Liu, D., Warden, S. J., Li, J., Maye, P., Rowe, D. W., Duncan, R. L., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601000200 · Cited by 397
Almeida, M., Han, L., Bellido, T., Manolagas, S. C., & Kousteni, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502168200 · Cited by 395
Calvi, L. M., Sims, N. A., Hunzelman, J. L., Knight, M. C., Giovannetti, A., Saxton, J. M., Kronenberg, H. M., Baron, R., & Schipani, E. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11296 · Cited by 388
Riggs, B. L., & Parfitt, A. M. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041114 · Cited by 380
Bellido, T., Ali, A. A., Plotkin, L. I., Fu, Q., Gubrij, I., Roberson, P. K., Weinstein, R. S., O'Brien, C. A., Manolagas, S. C., & Jilka, R. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307444200 · Cited by 378
Self-citationTUNEL Apoptotic Cell Detection in Tissue Sections: Critical Evaluation and Improvement
Labat-Moleur, F., Guillermet, C., Lorimier, P., Robert, C., Lantuejoul, S., Brambilla, E., & Negoescu, A. (1998) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549804600306 · Cited by 351
Ishizuya, T., Yokose, S., Hori, M., Noda, T., Suda, T., Yoshiki, S., & Yamaguchi, A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119491 · Cited by 349
Parathyroid hormone: past and present
Potts, J. T. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06057 · Cited by 327
Dobnig, H. (1997) · Endocrinology · doi:10.1210/en.138.11.4607 · Cited by 322
Parathyroid hormone and parathyroid hormone-related peptide, and their receptors
Gensure, R. C., Gardella, T. J., & Jüppner, H. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.069 · Cited by 301
Regulation of Bone Mass in Mice by the Lipoxygenase Gene Alox15
Klein, R. F., Allard, J., Avnur, Z., Nikolcheva, T., Rotstein, D., Carlos, A. S., Shea, M., Waters, R. V., Belknap, J. K., Peltz, G., et al. (2004) · Science · doi:10.1126/science.1090985 · Cited by 296
Wronski, T. J. (1993) · Endocrinology · doi:10.1210/en.132.2.823 · Cited by 290
Lindsay, R., Cosman, F., Zhou, H., Bostrom, M. P., Shen, V. W., Cruz, J. D., Nieves, J. W., & Dempster, D. W. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.051109 · Cited by 277
Miao, D. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24918 · Cited by 277
Bikle, D. D., Sakata, T., Leary, C., Elalieh, H., Ginzinger, D., Rosen, C. J., Beamer, W., Majumdar, S., & Halloran, B. P. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.9.1570 · Cited by 259
Han, Z.-H., Palnitkar, S., Rao, D. S., Nelson, D., & Parfitt, A. M. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.4.498 · Cited by 252
Daily and Cyclic Parathyroid Hormone in Women Receiving Alendronate
Cosman, F., Nieves, J., Zion, M., Woelfert, L., Luckey, M., & Lindsay, R. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050157 · Cited by 250
Lindsay, R., Zhou, H., Cosman, F., Nieves, J., Dempster, D. W., & Hodsman, A. B. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070104 · Cited by 233
Ma, Y. L., Zeng, Q., Donley, D. W., Ste-Marie, L.-G., Gallagher, J. C., Dalsky, G. P., Marcus, R., & Eriksen, E. F. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060314 · Cited by 229
Marcus, R., Wang, O., Satterwhite, J., & Mitlak, B. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.1.18 · Cited by 227
Arlot, M., Meunier, P. J., Boivin, G., Haddock, L., Tamayo, J., Correa-Rotter, R., Jasqui, S., Donley, D. W., Dalsky, G. P., Martin, J. S., et al. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050309 · Cited by 226
Transcriptional Activation of the p21 Gene by Interleukin-6 Type Cytokines
Bellido, T., O'Brien, C. A., Roberson, P. K., & Manolagas, S. C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.33.21137 · Cited by 224
LRP5 Mutations Linked to High Bone Mass Diseases Cause Reduced LRP5 Binding and Inhibition by SOST
Semenov, M. V., & He, X. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609509200 · Cited by 222
Locklin, R. M., Khosla, S., Turner, R. T., & Riggs, B. L. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10490 · Cited by 219
Frolik, C. A., Black, E. C., Cain, R. L., Satterwhite, J. H., Brown-Augsburger, P. L., Sato, M., & Hock, J. M. (2003) · Bone · doi:10.1016/s8756-3282(03)00202-3 · Cited by 211
Terminal osteoblast differentiation, mediated by runx2 and p27 KIP1, is disrupted in osteosarcoma
Thomas, D. M., Johnson, S. A., Sims, N. A., Trivett, M. K., Slavin, J. L., Rubin, B. P., Waring, P., McArthur, G. A., Walkley, C. R., Holloway, A. J., et al. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200409187 · Cited by 208
Canalis, E. (2010) · Fundamentals of Osteoporosis · doi:10.1016/b978-0-12-375098-3.50020-2 · Cited by 206
Mesenchymal Stem Cells and Osteoblast Differentiation
Aubin, J. E. (2008) · Principles of Bone Biology · doi:10.1016/b978-0-12-373884-4.00026-4 · Cited by 190
Horwitz, M. J., Tedesco, M. B., Gundberg, C., Garcia-Ocana, A., & Stewart, A. F. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021122 · Cited by 187
Dempster, D. W., Parisien, M., Silverberg, S. J., Liang, X.-G., Schnitzer, M., Shen, V., Shane, E., Kimmel, D. B., Recker, R., Lindsay, R., et al. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.5.5652 · Cited by 184
Delmas, P. D., Vergnaud, P., Arlot, M. E., Pastoureau, P., Meunier, P. J., & Nilssen, M. H. L. (1995) · Bone · doi:10.1016/8756-3282(95)00113-r · Cited by 171
Watson, P., Lazowski, D., Han, V., Fraher, L., Steer, B., & Hodsman, A. (1995) · Bone · doi:10.1016/8756-3282(94)00051-4 · Cited by 168
Parathyroid Hormone Bone Anabolic Action Requires Cbfa1/Runx2-Dependent Signaling
Krishnan, V., Moore, T. L., Ma, Y. L., Helvering, L. M., Frolik, C. A., Valasek, K. M., Ducy, P., & Geiser, A. G. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0225 · Cited by 162
Qin, L., Qiu, P., Wang, L., Li, X., Swarthout, J. T., Soteropoulos, P., Tolias, P., & Partridge, N. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212226200 · Cited by 161
Black, D. M., Greenspan, S. L., Ensrud, K. E., Palermo, L., McGowan, J. A., Lang, T. F., Garnero, P., Bouxsein, M. L., Bilezikian, J. P., & Rosen, C. J. (2004) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000115856.54444.d6 · Cited by 159
Rickard, D. J., Wang, F., Rodriguez-Rojas, A.-M., Wu, Z., Trice, W. J., Hoffman, S. J., Votta, B. J., Stroup, G. B., Kumar, S., & NUTTALL, M. E. (2006) · Bone · doi:10.1016/j.bone.2006.06.010 · Cited by 157
Onyia, J. E., Bidwell, J. P., Herring, J., Hulman, J. F., & Hock, J. M. (1995) · Bone · doi:10.1016/8756-3282(95)00332-2 · Cited by 157
Evidence That Anabolic Effects of PTH on Bone Require IGF-I in Growing Mice
Miyakoshi, N., Kasukawa, Y., Linkhart, T. A., Baylink, D. J., & Mohan, S. (2001) · Endocrinology · doi:10.1210/endo.142.10.8436 · Cited by 155
Dempster, D. W. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.5.1562 · Cited by 155
Sato, M., Westmore, M. S., Ma, Y. L., Schmidt, A., Zeng, Q. Q., Glass, E. V., Vahle, J. L., Brommage, R., Jerome, C. P., & Turner, C. H. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040112 · Cited by 153
Iida‐Klein, A., Zhou, H., Lu, S. S., Levine, L. R., Ducayen, M. B., Dempster, D. W., Nieves, J. W., & Lindsay, R. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.5.808 · Cited by 146
Nakazawa, T., Nakajima, A., Shiomi, K., Moriya, H., Einhorn, T. A., & Yamazaki, M. (2005) · Bone · doi:10.1016/j.bone.2005.06.013 · Cited by 142
Chen, H.-L., Demiralp, B., Schneider, A., Koh, A. J., Silve, C., Wang, C. Y., & McCauley, L. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108913200 · Cited by 142
Mechanical stimulation in vivo reduces osteocyte expression of sclerostin.
Robling, A. G., Bellido, T., & Turner, C. H. (2006) · PubMed · Cited by 141
Swarthout, J. T., Doggett, T. A., Lemker, J. L., & Partridge, N. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007400200 · Cited by 140
Fermor, B., & Skerry, T. M. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650101213 · Cited by 133
Osteoblast-derived PTHrP is a physiological regulator of bone formation
Martin, T. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26239 · Cited by 132
Bone Response to Intermittent Parathyroid Hormone Is Altered in Mice Null for β-Arrestin2
Ferrari, S., Pierroz, D. D., Glatt, V., Goddard, D. S., Bianchi, E. N., Lin, F., Manen, D., & Bouxsein, M. (2005) · Endocrinology · doi:10.1210/en.2004-1282 · Cited by 131
Kim, C. H., Takai, E., Zhou, H., Stechow, D. V., Müller, R., Dempster, D. W., & Guo, X.-D. E. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.12.2116 · Cited by 129
Kostenuik, P. J., Harris, J., Halloran, B. P., Turner, R. T., Morey-Holton, E. R., & Bikle, D. D. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.1.21 · Cited by 119
Cyclin D1-Cdk4 Induce Runx2 Ubiquitination and Degradation
Shen, R., Wang, X., Drissi, H., Liu, F., O’Keefe, R. J., & Chen, D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603439200 · Cited by 117
Miao, D., Li, J., Xue, Y., Su, H., Karaplis, A. C., & Goltzman, D. (2004) · Endocrinology · doi:10.1210/en.2003-1695 · Cited by 117
Leaffer, D., Sweeney, M., Kellerman, L., et al. (1995) · Endocrinology · doi:10.1210/endo.136.8.7628402 · Cited by 116
Alendronate Does Not Block the Anabolic Effect of PTH in Postmenopausal Osteoporotic Women
Cosman, F., Nieves, J. W., Woelfert, L., Shen, V., & Lindsay, R. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.6.1051 · Cited by 114
PARFITT, A. M., Han, Z.-H., Palnitkar, S., Rao, D. S., Shih, M. S., & Nelson, D. A. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.11.1864 · Cited by 113
Miao, D., Tong, X., Chan, G. K., Panda, D. K., McPherson, P. S., & Goltzman, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101084200 · Cited by 111
Hurley, M. M., Tetradis, S., Huang, Y., Hock, J. M., Kream, B. E., Raisz, L. G., & Sabbieti, M. G. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.5.776 · Cited by 110
Hall, B. K. (1990) · Medical Entomology and Zoology · Cited by 104
Grey, A. B., Chen, Q., Xu, X., Callon, K. E., & Cornish, J. (2003) · Endocrinology · doi:10.1210/en.2003-0350 · Cited by 102
PTH Stimulates Bone Formation in Mice Deficient in Lrp5
Iwaniec, U. T., Wronski, T. J., Liu, J., Rivera, M. F., Arzaga, R. R., Hansen, G. M., & Brommage, R. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.061118 · Cited by 102
Vilardaga, J., Krasel, C., Chauvin, S., Bambino, T., Lohse, M. J., & Nissenson, R. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110433200 · Cited by 101
Apoptosis in murine calvarial bone and suture development
Rice, D. P. C., Kim, H., & Thesleff, I. (1999) · European Journal Of Oral Sciences · doi:10.1046/j.0909-8836.1999.eos107406.x · Cited by 101
Hosking, D. J. (2001) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2001.01165.x · Cited by 100
Iahizuya, T. (1997) · Journal of Clinical Investigation · Cited by 100
Lane, N. E., Yao, W., Kinney, J. H., Modin, G. W., Balooch, M., & Wronski, T. J. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.12.2105 · Cited by 99
Qin, L., Li, X., Ko, J., & Partridge, N. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409846200 · Cited by 92
Ma, Y. L., Bryant, H. U., Zeng, Q., Schmidt, A., Hoover, J. L., Cole, H. W., Yao, W., Jee, W. S. S., & Sato, M. (2003) · Endocrinology · doi:10.1210/en.2002-221061 · Cited by 91
Insulin Receptor Substrate-1 Is Required for Bone Anabolic Function of Parathyroid Hormone in Mice
Yamaguchi, M., Ogata, N., Shinoda, Y., Akune, T., Kamekura, S., Terauchi, Y., Kadowaki, T., Hoshi, K., Chung, U., Nakamura, K., et al. (2005) · Endocrinology · doi:10.1210/en.2004-1511 · Cited by 90
Zhou, H., Iida‐Klein, A., Lu, S. S., Ducayen, M. B., Levine, L. R., Dempster, D. W., & Lindsay, R. (2003) · Bone · doi:10.1016/s8756-3282(03)00057-7 · Cited by 89
Pettway, G. J., SCHNEIDER, A., KOH, A., Widjaja, E., MORRIS, M., Meganck, J. A., Goldstein, S. A., & McCauley, L. K. (2005) · Bone · doi:10.1016/j.bone.2005.02.015 · Cited by 86
Ma, Y., Jee, W. S. S., Yuan, Z., et al. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.3.439 · Cited by 85
Chan, G. K., Deckelbaum, R. A., Bolivar, I., Goltzman, D., & Karaplis, A. C. (2001) · Endocrinology · doi:10.1210/endo.142.11.8515 · Cited by 85
Impaired bone anabolic response to parathyroid hormone in Fgf2−/− and Fgf2+/− mice
Hurley, M. M., Okada, Y., Xiao, L., Tanaka, Y., Ito, M., Okimoto, N., Nakamura, T., Rosen, C. J., Doetschman, T., & Coffin, J. D. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.01.044 · Cited by 82
Samadfam, R., Xia, Q., & Goltzman, D. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060915 · Cited by 80
Yakar, S., Bouxsein, M., CANALIS, E. M., Sun, H., Glatt, V., Gundberg, C. G., Cohen, P., Hwang, D., Boisclair, Y. R., LeRoith, D., et al. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06657 · Cited by 80
Bergmann, A. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01584-6 · Cited by 79
PTHrP Signaling Targets Cyclin D1 and Induces Osteoblastic Cell Growth Arrest
Datta, N. S., Chen, C., Berry, J. E., & McCauley, L. K. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050106 · Cited by 77
Stanislaus, D., Yang, X., Liang, J., Wolfe, J. M. T., Cain, R. L., Onyia, J. E., Falla, N., Marder, P., Bidwell, J. P., Queener, S. W., et al. (2000) · Bone · doi:10.1016/s8756-3282(00)00309-4 · Cited by 72
Miles, R. R., Sluka, J. P., Halladay, D. L., et al. (2000) · Endocrinology · doi:10.1210/endo.141.12.7817 · Cited by 66
Turner, R. T., Lotinun, S., Hefferan, T. E., & Morey, E. R. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01622.2005 · Cited by 58
Stretch-Induced PTH-Related Protein Gene Expression in Osteoblasts
Chen, X., Macica, C. M., Ng, K. W., & Broadus, A. E. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2005.20.8.1454 · Cited by 53
McClelland, P., Onyia, J. E., Miles, R. R., Tu, Y., Liang, J., Harvey, A. K., Chandrasekhar, S., Hock, J. M., & Bidwell, J. P. (1998) · Journal of Cellular Biochemistry · Cited by 53
The Effect of Aging on the Skeletal Response to Intermittent Treatment with Parathyroid Hormone
Knopp, E. A., Troiano, N. W., Bouxsein, M., Sun, B., Lostritto, K., Gundberg, C. M., Dziura, J. D., & Insogna, K. L. (2004) · Endocrinology · doi:10.1210/en.2004-0770 · Cited by 52
Sakai, A., Sakata, T., Ikeda, S., Uchida, S., Okazaki, R., Norimura, T., Hori, M., & Nakamura, T. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.10.1691 · Cited by 49
Proliferating cells in the primary spongiosa express osteoblastic phenotype in vitro
Onyia, J. E., Miller, B., Hulman, J. F., Liang, J., Galvin, R. J. S., Frolik, C. A., Chandrasekhar, S., Harvey, A. K., Bidwell, J. P., Herring, J., et al. (1997) · Bone · doi:10.1016/s8756-3282(96)00350-x · Cited by 48
The anabolic effect of PTH on bone is attenuated by simultaneous glucocorticoid treatment
Oxlund, H., Ørtoft, G., Thomsen, J. S., Danielsen, C. C., Ejersted, C., & Andreassen, T. T. (2006) · Bone · doi:10.1016/j.bone.2006.01.142 · Cited by 43
Boyce, B. F., Hughes, D. E., Wright, K. R., Xing, L., & Dai, A. (1998) · Springer eBooks · doi:10.1007/978-3-662-09007-7_3 · Cited by 37
Iida‐Klein, A., Lu, S. S., Cosman, F., Lindsay, R., & Dempster, D. W. (2006) · Bone · doi:10.1016/j.bone.2006.09.010 · Cited by 37
CREM deficiency in mice alters the response of bone to intermittent parathyroid hormone treatment
Liu, F., Lee, S., Adams, D. J., Gronowicz, G., & Kream, B. E. (2007) · Bone · doi:10.1016/j.bone.2006.12.003 · Cited by 31
Rapid new bone tissue remodeling during distraction osteogenesis is associated with apoptosis
Li, G., Dickson, G. R., Marsh, D., & Simpson, H. (2002) · Journal of Orthopaedic Research® · doi:10.1016/s0736-0266(02)00097-9 · Cited by 24
Cytokines in Primary Hyperparathyroidism
Nakchbandi, I. A., Grey, A. B., MASIUKIEWICZ, U. S., Mitnick, M., & Insogna, K. L. (2001) · Elsevier eBooks · doi:10.1016/b978-012098651-4/50027-4 · Cited by 4
Cited by
Bone grafts and biomaterials substitutes for bone defect repair: A review
Wang, W., & Yeung, K. W. K. (2017) · Bioactive Materials · doi:10.1016/j.bioactmat.2017.05.007 · Cited by 1,938
A comprehensive overview on osteoporosis and its risk factors
Pouresmaeili, F., Kamali Dehghan, B., Kamarehei, M., & Yong Meng, G. (2018) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s138000 · Cited by 597
Parathyroid hormone: anabolic and catabolic actions on the skeleton
Silva, B. C., & Bilezikian, J. P. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.03.005 · Cited by 557
Advances in pathogenesis and therapeutic strategies for osteoporosis
Song, S., Guo, Y., Yang, Y., & Fu, D. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108168 · Cited by 476
The Role of Liver-Derived Insulin-Like Growth Factor-I
Ohlsson, C., Mohan, S., Sjögren, K., Tivesten, A., Isgaard, J., Isaksson, O., Jansson, J.-O., & Svensson, J. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0010 · Cited by 453
Metadata
- Authors
- Jilka, R. L.
- Venue
- Bone
- Publisher
- Elsevier BV
- Published
- 2007-06
- Volume
- 40
- Issue
- 6
- Pages
- 1434-1446
- ISSN
- 1873-2763 (ISSN-L)
- 8756-3282
- OpenAlex
- W2099028287
- Cited by
- 720
- References
- 119
- FWCI
- 16.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.